» Articles » PMID: 28325873

Priming GPCR Signaling Through the Synergistic Effect of Two G Proteins

Overview
Specialty Science
Date 2017 Mar 23
PMID 28325873
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Although individual G-protein-coupled receptors (GPCRs) are known to activate one or more G proteins, the GPCR-G-protein interaction is viewed as a bimolecular event involving the formation of a ternary ligand-GPCR-G-protein complex. Here, we present evidence that individual GPCR-G-protein interactions can reinforce each other to enhance signaling through canonical downstream second messengers, a phenomenon we term "GPCR priming." Specifically, we find that the presence of noncognate Gq protein enhances cAMP stimulated by two Gs-coupled receptors, β2-adrenergic receptor (β2-AR) and D dopamine receptor (D-R). Reciprocally, Gs enhances IP through vasopressin receptor (V-R) but not α1 adrenergic receptor (α1-AR), suggesting that GPCR priming is a receptor-specific phenomenon. The C terminus of either the Gαs or Gαq subunit is sufficient to enhance Gα subunit activation and cAMP levels. Interaction of Gαs or Gαq C termini with the GPCR increases signaling potency, suggesting an altered GPCR conformation as the underlying basis for GPCR priming. We propose three parallel mechanisms involving () sequential G-protein interactions at the cognate site, () G-protein interactions at distinct allosteric and cognate sites on the GPCR, and () asymmetric GPCR dimers. GPCR priming suggests another layer of regulation in the classic GPCR ternary-complex model, with broad implications for the multiplicity inherent in signaling networks.

Citing Articles

The sphingosine-1-phosphate receptor 1 mediates the atheroprotective effect of eicosapentaenoic acid.

Zhou T, Cheng J, He S, Zhang C, Gao M, Zhang L Nat Metab. 2024; 6(8):1566-1583.

PMID: 38907081 DOI: 10.1038/s42255-024-01070-3.


Hsp70 and Hsp90 Elaborately Regulate RNAi Efficiency in .

Lin S, Yang J, Wang W, Huang P, Asad M, Yang G Int J Mol Sci. 2023; 24(22).

PMID: 38003357 PMC: 10671170. DOI: 10.3390/ijms242216167.


Endogenous μ-opioid-Neuropeptide Y Y1 receptor synergy silences chronic postoperative pain in mice.

Nelson T, Santos D, Prasoon P, Gralinski M, Allen H, Taylor B PNAS Nexus. 2023; 2(8):pgad261.

PMID: 37649580 PMC: 10465188. DOI: 10.1093/pnasnexus/pgad261.


Autoregulation of GPCR signalling through the third intracellular loop.

Sadler F, Ma N, Ritt M, Sharma Y, Vaidehi N, Sivaramakrishnan S Nature. 2023; 615(7953):734-741.

PMID: 36890236 PMC: 10033409. DOI: 10.1038/s41586-023-05789-z.


Anionic phospholipids control mechanisms of GPCR-G protein recognition.

Thakur N, Ray A, Sharp L, Jin B, Duong A, Pour N Nat Commun. 2023; 14(1):794.

PMID: 36781870 PMC: 9925817. DOI: 10.1038/s41467-023-36425-z.


References
1.
Rasenick M, Watanabe M, Lazarevic M, Hatta S, Hamm H . Synthetic peptides as probes for G protein function. Carboxyl-terminal G alpha s peptides mimic Gs and evoke high affinity agonist binding to beta-adrenergic receptors. J Biol Chem. 1994; 269(34):21519-25. View

2.
Chung K, Rasmussen S, Liu T, Li S, DeVree B, Chae P . Conformational changes in the G protein Gs induced by the β2 adrenergic receptor. Nature. 2011; 477(7366):611-5. PMC: 3448949. DOI: 10.1038/nature10488. View

3.
Hermans E . Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors. Pharmacol Ther. 2003; 99(1):25-44. DOI: 10.1016/s0163-7258(03)00051-2. View

4.
Berchiche Y, Sakmar T . CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways. Mol Pharmacol. 2016; 90(4):483-95. DOI: 10.1124/mol.116.105502. View

5.
Swanson C, Sivaramakrishnan S . Harnessing the unique structural properties of isolated α-helices. J Biol Chem. 2014; 289(37):25460-7. PMC: 4162150. DOI: 10.1074/jbc.R114.583906. View